UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Directly observed therapy for treating tuberculosis

Cochrane database of systematic reviews, 2007-10 (4), p.CD003343

2007

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the impact that the changes in tuberculosis treatment implemented in Brazil in 2009 have had on disease control in the country

Jornal brasileiro de pneumologia, 2017-11, Vol.43 (6), p.437-444

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

The New England journal of medicine, 2020-03, Vol.382 (10), p.893-902

2020

Link zum Volltext

Verfügbarkeit prüfen

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children

Cochrane database of systematic reviews, 2020-08, Vol.8 (8), p.CD013359

2020

Link zum Volltext

Verfügbarkeit prüfen

Low access to a highly effective therapy: a challenge for international tuberculosis control

Bulletin of the World Health Organization, 2002-01, Vol.80 (6), p.437-444

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2019-11, Vol.200 (10), p.e93-e142

2019

Link zum Volltext

Verfügbarkeit prüfen

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Nature medicine, 2018-11, Vol.24 (11), p.1708-1715

2018

Link zum Volltext

Verfügbarkeit prüfen

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

The European respiratory journal, 2020-07, Vol.56 (1), p.2001398

2020

Link zum Volltext

Verfügbarkeit prüfen

Rifabutin for treating pulmonary tuberculosis

Cochrane database of systematic reviews, 2007-10 (4), p.CD005159

2007

Link zum Volltext

Verfügbarkeit prüfen

Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions

Nature medicine, 2020-04, Vol.26 (4), p.529-534

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children

Cochrane database of systematic reviews, 2009-01 (1), p.CD006418

2009

Link zum Volltext

Verfügbarkeit prüfen

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

The Lancet (British edition), 2019-03, Vol.393 (10178), p.1331-1384

2019

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization

PLoS medicine, 2019-04, Vol.16 (4), p.e1002773

2019

Link zum Volltext

Verfügbarkeit prüfen

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

The European respiratory journal, 2016-08, Vol.48 (2), p.516-525

2016

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis, Pulmonary Cavitation, and Matrix Metalloproteinases

American journal of respiratory and critical care medicine, 2014-07, Vol.190 (1), p.9-18

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

The Lancet (British edition), 2018-09, Vol.392 (10150), p.821-834

2018

Link zum Volltext

Verfügbarkeit prüfen

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children

Cochrane database of systematic reviews, 2022-09, Vol.9 (9), p.CD013359-CD013359

2022

Link zum Volltext

Verfügbarkeit prüfen

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Cochrane database of systematic reviews, 2021-02, Vol.2, p.CD009593

2021

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis: A disease without boundaries

Tuberculosis (Edinburgh, Scotland), 2015-09, Vol.95 (5), p.527-531

Fogel, Nicole

2015

Link zum Volltext

Verfügbarkeit prüfen

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis

The international journal of tuberculosis and lung disease, 2014-09, Vol.18 (9), p.1019-1025

2014

Link zum Volltext

Verfügbarkeit prüfen

Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples

Journal of clinical microbiology, 2017-05, Vol.55 (5), p.1285-1298

2017

Link zum Volltext

Verfügbarkeit prüfen

Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)

Tuberculosis (Edinburgh, Scotland), 2018-07, Vol.111, p.20-30

2018

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives

FEMS microbiology reviews, 2017-05, Vol.41 (3), p.354-373

2017

Link zum Volltext

Verfügbarkeit prüfen

Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa

Emerging infectious diseases, 2013-03, Vol.19 (3), p.449-455

2013

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3

Antimicrobial agents and chemotherapy, 2016-09, Vol.60 (9), p.5198-5207

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 17.936

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.675)
Mit Volltextzugriff
(8.529)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(11.616)
Russisch
(2.422)
Japanisch
(1.390)
Französisch
(833)
Deutsch
(799)
Italienisch
(446)
Polnisch
(444)
Spanisch
(348)
Rumänisch
(269)
Portugiesisch
(211)
Chinesisch
(164)
Croatian
(87)
Ukrainisch
(52)
Niederländisch
(37)
Ungarisch
(34)
Serbian
(30)
Türkisch
(24)
Dänisch
(21)
Tschechisch
(20)
Slowakisch
(17)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(16.838)
Tuberculosis, Pulmonary - Drug Therapy
(14.002)
Male
(9.096)
Science & Technology
(8.382)
Female
(8.311)
Adult
(8.069)
Life Sciences & Biomedicine
(8.028)
Antitubercular Agents - Therapeutic Use
(6.989)
Middle Aged
(6.537)
Tuberculosis
(4.938)
Aged
(3.529)
Adolescent
(3.519)
Infectious Diseases
(3.254)
Tuberculosis, Pulmonary - Diagnosis
(2.907)
Respiratory System
(2.814)
Drug Therapy, Combination
(2.520)
Biological And Medical Sciences
(2.482)
Medical Sciences
(2.439)
Tuberculosis, Pulmonary - Microbiology
(2.298)
Tuberculosis, Pulmonary - Complications
(2.230)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Problemy Tuberkuleza
(1.453)
The International Journal Of Tuberculosis And Lung Disease
(839)
Kekkaku
(488)
Tuberculosis
(328)
The American Review Of Respiratory Disease
(292)
Tubercle
(286)
Plos One
(270)
Clinical Infectious Diseases
(251)
Chest
(246)
Gruzlica I Choroby Pluc; Tuberculosis Et Pneumonologia
(228)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Directly observed therapy for treating tuberculosis

Evaluation of the impact that the changes in tuberculosis treatment implemented in Brazil in 2009 have had on disease control in the country

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children

Low access to a highly effective therapy: a challenge for international tuberculosis control

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

Rifabutin for treating pulmonary tuberculosis

Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions

Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Tuberculosis, Pulmonary Cavitation, and Matrix Metalloproteinases

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Tuberculosis: A disease without boundaries

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis

Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples

Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)

Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives

Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa

Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3

Suchergebnisse filtern